Get the latest Sabra Health Care REIT, Inc. (SBRA) stock news and headlines to help you in your trading and investing decisions.

Sabra Health Care REIT (NASDAQ:SBRA) is preparing to release its quarterly earnings on Monday, 2025-05-05. Here's a brief overview of what investors should keep in mind before the announcement.

Sabra Health Care REIT (SBRA-0.76%) is one such company, and its stock price gain of more than 8.6% year to date makes it look especially appealing, ...

Sabra Health Care is trading at a discounted book value due to Covid-19 and operator concerns, but I see this as an opportunity to buy the REIT, particularly because credit metrics are high enough ...

Sabra Health Care REIT, Inc. to Participate in Nareit’s REITweek 2025 Investor Conference and Attend ASHA’s 2025 Mid-Year Meeting Business Wire May 22, 2025, 8:05:00 PM ...

What happened. Shares of Sabra Health Care REIT (SBRA 0.80%) surged 20.2% in May, according to data provided by S&P Global Market Intelligence.The healthcare-focused real estate investment trust ...

Is Sabra Health Care REIT, Inc. (NASDAQ:SBRA) a good dividend stock? How can we tell? Dividend paying companies with growing earnings can be highly rewarding in the long term. Yet sometimes ...

Analysts have recently evaluated Sabra Health Care REIT and provided 12-month price targets. The average target is $19.25, accompanied by a high estimate of $20.00 and a low estimate of $17.00.

Sabra Health Care REIT: A High-Yielding Gift Just In Time For The New Year; Sabra Health Care FFO of $0.36 beats by $0.01, ...

Sabra Health Care REIT, Inc.’s revenue estimate for 2025 is $742.16M. The latest low revenue estimate is $706.87M and the high revenue estimate is $781.91M.

Sabra Health Care REIT (SBRA) is scheduled to report earnings on August 6, 2025. The last reported earnings were for reported on May 5, 2025 for Q1 ...

Sabra Health Care REIT has no upcoming dividends reported. The last reported dividend for Sabra Health Care REIT (SBRA) was $0.30 and was paid out on May 30, 2025. Q.